Literature DB >> 12787776

Nuclear mRNA surveillance.

Shobha Vasudevan1, Stuart W Peltz.   

Abstract

Recent studies demonstrate that the factors involved in mRNA processing specify the fate of a transcript. The mRNA is either committed for export to the cytoplasm or accumulates in the nucleus, where it may be degraded. These studies reveal crosstalk among the nuclear events faced by the pre-mRNA. It is becoming evident that the components of the mRNA synthesis machinery interact with each other to establish a distinct surveillance mechanism that determines release of the transcript from the transcription site for further export and utilisation. Recent advances suggest that the major nuclear decay machinery, the nuclear exosome, and an Rrp6p-specific complex coordinate with processing factors to perform a unique regulatory function that determines its fate: either confinement of the defective mRNA at its transcription site, or release from its site of transcription for further processing and export or decay. Furthermore, message-specific regulatory mechanisms correspond with the nuclear mRNA synthesis machinery to control gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787776     DOI: 10.1016/s0955-0674(03)00051-6

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  32 in total

1.  Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs.

Authors:  Ashish Lal; Krystyna Mazan-Mamczarz; Tomoko Kawai; Xiaoling Yang; Jennifer L Martindale; Myriam Gorospe
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 2.  The exozyme model: a continuum of functionally distinct complexes.

Authors:  Daniel L Kiss; Erik D Andrulis
Journal:  RNA       Date:  2010-11-10       Impact factor: 4.942

3.  A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts.

Authors:  Nicholas K Conrad; Joan A Steitz
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

Review 4.  A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts.

Authors:  Didier Auboeuf; Dennis H Dowhan; Martin Dutertre; Natalia Martin; Susan M Berget; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  The imprinted Air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export.

Authors:  Christine I M Seidl; Stefan H Stricker; Denise P Barlow
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

6.  Depletion of the yeast nuclear exosome subunit Rrp6 results in accumulation of polyadenylated RNAs in a discrete domain within the nucleolus.

Authors:  Tiago Carneiro; Célia Carvalho; José Braga; José Rino; Laura Milligan; David Tollervey; Maria Carmo-Fonseca
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

7.  Balance between transcription and RNA degradation is vital for Saccharomyces cerevisiae mitochondria: reduced transcription rescues the phenotype of deficient RNA degradation.

Authors:  Agata T Rogowska; Olga Puchta; Anna M Czarnecka; Aneta Kaniak; Piotr P Stepien; Pawel Golik
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

8.  Ectopic 5' splice sites inhibit gene expression by engaging RNA surveillance and silencing pathways in plants.

Authors:  Krzysztof Wypijewski; Csaba Hornyik; Jane A Shaw; Jennifer Stephens; Rafal Goraczniak; Samuel I Gunderson; Christophe Lacomme
Journal:  Plant Physiol       Date:  2009-08-07       Impact factor: 8.340

Review 9.  RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.

Authors:  Karen C M Moraes
Journal:  Mol Med       Date:  2009-10-07       Impact factor: 6.354

10.  The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation.

Authors:  Sunnie M Yoh; Joseph S Lucas; Katherine A Jones
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.